Z Factor Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Z Factor General Information

Description

Developer of a drug discovery company intended to identify therapeutic agents to treat alpha-1-antitrypsin deficiency. The company's activities are focused on designing and developing novel therapeutic agents to correct the misfolding of the Z variant of alpha-1-antitrypsin, thereby addressing an important and unmet medical need where current treatments are limited to lung or liver transplantation and augmentation therapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • The Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • The Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Z Factor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 16-Feb-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 03-May-2017 Completed Startup
2. Early Stage VC (Series A) 05-Feb-2015 $1.66M $1.66M Completed Startup
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Z Factor’s complete valuation and funding history, request access »

Z Factor Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Z Factor’s complete cap table history, request access »

Z Factor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery company intended to identify therapeutic agents to treat alpha-1-antitrypsin deficiency. T
Drug Discovery
Cambridge, United Kingdom
1 As of 2022

Lexington, MA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Z Factor Competitors (48)

One of Z Factor’s 48 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
Numerion Labs Venture Capital-Backed San Francisco, CA
Metacrine Formerly VC-backed San Diego, CA
X-37 Venture Capital-Backed South San Francisco, CA
insitro Venture Capital-Backed South San Francisco, CA
You’re viewing 5 of 48 competitors. Get the full list »

Z Factor Patents

Z Factor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022263829-A1 Compounds and their use for the treatment of α1-antitrypsin deficiency Inactive 16-Jun-2021
GB-202108523-D0 Compositions and their use for the treatment of alpha1-antitrypsin deficiency Inactive 15-Jun-2021
WO-2022263816-A1 Compositions and their use for the treatment of α1-antitrypsin deficiency Inactive 15-Jun-2021
GB-202108497-D0 Compounds Inactive 15-Jun-2021
GB-202108499-D0 Compounds Inactive 15-Jun-2021 C07D403/10
To view Z Factor’s complete patent history, request access »

Z Factor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Z Factor Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambridge Enterprise Ventures Venture Capital Minority
Cambridge Innovation Capital Venture Capital Minority
Medicxi Ventures (UK) Venture Capital Minority
To view Z Factor’s complete investors history, request access »

Z Factor FAQs

  • When was Z Factor founded?

    Z Factor was founded in 2015.

  • Where is Z Factor headquartered?

    Z Factor is headquartered in Cambridge, United Kingdom.

  • What is the size of Z Factor?

    Z Factor has 1 total employees.

  • What industry is Z Factor in?

    Z Factor’s primary industry is Drug Discovery.

  • Is Z Factor a private or public company?

    Z Factor is a Private company.

  • What is Z Factor’s current revenue?

    The current revenue for Z Factor is .

  • How much funding has Z Factor raised over time?

    Z Factor has raised $10.5M.

  • Who are Z Factor’s investors?

    Cambridge Enterprise Ventures, Cambridge Innovation Capital, and Medicxi Ventures (UK) have invested in Z Factor.

  • Who are Z Factor’s competitors?

    Voyager Therapeutics, Numerion Labs, Metacrine, X-37, and insitro are some of the 48 competitors of Z Factor.

  • When was Z Factor acquired?

    Z Factor was acquired on 16-Feb-2021.

  • Who acquired Z Factor?

    Z Factor was acquired by Centessa Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process